isatuximab-irfc
FDA Approves Sarclisa With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
The FDA has approved Sarclisa with bortezomib, lenalidomide and dexamethasone for adults with newly diagnosed ...
SEPTEMBER 23, 2024
New Monoclonal Antibody Approved to Treat Relapsed/Refractory MM
The FDA approved isatuximab-irfc (Sarclisa, Sanofi) in combination with pomalidomide (Pomalyst, Celgene) and ...
MARCH 3, 2020
Load more